AmerisourceBergen

About

AmerisourceBergen is a global healthcare company that advances the development and delivery of pharmaceuticals and healthcare products.

Valley Forge,Pennsylvania,United States
10001 - max
http://www.amerisourcebergen.com

Highlights

Details

Last Funding Type: Post-IPO Secondary
Last Funding Money Raised: $500M
Industries: Emergency Medicine,Enterprise Software,Health Care,Medical,Pharmaceutical
Founded date: Jan 1, 1907
Number Of Employee: 10001 - max
Operating Status: Active
Stock Symbol: nyse:ABC
Legal Name: AmerisourceBergen Corp.

AmerisourceBergen Corporation is one of the world's largest pharmaceutical services companies serving global markets with a focus on the pharmaceutical supply chain. Servicing both pharmaceutical manufacturers and healthcare providers, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. Their scale, their position in the healthcare industry, and the value they bring to the channel have all helped their business continue to succeed.

Headquartered in Valley Forge, Pennsylvania, AmerisourceBergen has locations around the world. It handles about 20% of all of the pharmaceuticals sold and distributed throughout the U.S.

They strive to take costs out of the healthcare system by using their scale and efficient operations to drive value for their customers. In addition to delivering pharmaceuticals on a just-in-time basis to tens of thousands of healthcare providers every day, they provide business support and consulting services to help their customers focus on their key strength—caring for patients.

AmerisourceBergen is committed to the safety and security of the nation’s pharmaceutical supply chain. They purchase all branded and generic pharmaceuticals only directly from the product’s manufacturer, except in the rare instance that they are required to do otherwise either by the manufacturer or a government agency.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$2.52B

AmerisourceBergen has raised a total of $2.52B in funding over 2 rounds. Their latest funding was raised on Nov 7, 2022 from a Post-IPO Secondary round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 7, 2022	Post-IPO Secondary	$500M	—	—	—	Detail
Mar 30, 2021	Post-IPO Debt	$1.52B	—	—	—	Detail
May 19, 2020	Post-IPO Debt	$500M	—	—	—	Detail
Apr 13, 1995	IPO	—	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

10

2

AmerisourceBergen has made 10 investments. Their most recent investment was on Oct 25, 2022, when WhizAI raised $6M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Oct 25, 2022 WhizAI	Series A	$6M	Analytics	Yes
Sep 29, 2022 WhizAI	Series A	$8M	Analytics	—
Jul 29, 2021 Secured Finance	Seed	$4M	Blockchain	—
Mar 3, 2021 TrakCel	Corporate Round	—	Clinical Trials	Yes
Mar 1, 2017 Forge	Series A	$3M	Finance	—

Employee Profiles

Number of Employee Profiles

33

AmerisourceBergen has 33 current employee profiles, including Board member Henry W. McGee

Board member

Executive

Executive

Executive

Executive

Exits

AmerisourceBergen has had 1 exits. AmerisourceBergen most notable exits include Profarma

Date	Company Name	Exit Type	Industry
Nov 3, 2006	Profarma	IPO	Pharmaceutical	Detail

Acquisition

AmerisourceBergen has acquired 23 organizations. Their most recent acquisition was Lash Group on Dec 1, 1998. They acquired Lash Group for 0.

Date Company Name	Industry	Acquisition Type	Price
Dec 1, 1998 Lash Group	Health Care	acquisition	—	Detail
Jun 21, 2000 Pharmacy Healthcare Solutions	Health Care	acquisition	—	Detail
Jun 20, 2002 AutoMed Technologies	Health Care	acquisition	$ 120M	Detail
Jan 6, 2003 Bridge Medical Inc	Information Technology	acquisition	$ 55M	Detail
Jan 17, 2003 US Bioservices	Biopharma	acquisition	$ 160M	Detail